Protective Effects of a Novel Lactobacillus brevis Strain with Probiotic Characteristics against Staphylococcus aureus Lipoteichoic Acid-Induced Intestinal Inflammatory Response

Won-Ju Kim,Jun-Hyun Hyun,Na-Kyoung Lee,Hyun-Dong Paik
DOI: https://doi.org/10.4014/jmb.2110.10034
2022-02-28
Journal of Microbiology and Biotechnology
Abstract:Probiotics can effectively modulate host immune responses and prevent gastrointestinal diseases. The objective of this study was to investigate the probiotic characteristics of <i>Lactobacillus brevis</i> KU15152 isolated from kimchi and its protective potential against intestinal inflammation induced by <i>Staphylococcus aureus</i> lipoteichoic acid (aLTA). <i>L. brevis</i> KU15152 exhibited a high survival rate in artificial gastric and bile environments. Additionally, the adhesion capability of the strain to HT-29 cells was higher than that of <i>L. rhamnosus</i> GG. <i>L. brevis</i> KU15152 did not produce harmful enzymes, such as β-glucuronidase, indicating that it could be used as a potential probiotic. The anti-inflammatory potential of <i>L. brevis</i> KU15152 was determined in HT-29 cells. Treatment with <i>L. brevis</i> KU15152 suppressed the production of interleukin-8 without inducing significant cytotoxicity. The downregulatory effects of <i>L. brevis</i> KU15152 were involved in the suppression of nuclear factor-kappa B activation mediated by the extracellular signal-regulated kinase and Akt signaling pathways. Collectively, these data suggest that <i>L. brevis</i> KU15152 can be used in developing therapeutic and prophylactic products to manage and treat aLTA-induced intestinal damage.
biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?